Clinical Care Highlights
We are one of the only adult programs in the country where patients can see multiple providers as part of the same visit in the same clinic. This makes it easier for the patient and allows providers to communicate plans in real time for optimal coordination of care. We also provide care in a gender neutral space to ensure patient comfort.
—Micol Rothman, MD
It is important to develop studies that represent the transgender and gender diverse populations we see in Colorado. Our results will help inform future research, contribute to improvements in gender-affirming care, and improve confidence that shared decision making between patients and providers is more evidence-based.
— Sean Iwamoto, MD
I've been struck over the past few years by how far some of my transgender patients need to travel to see me for gender-affirming care. My interest in being involved in our transgender ECHO program is rooted in the hope that with a little bit of education, over an extended period of time, more and more clinicians will be locally available for transgender individuals so that they don't have to be inconvenienced in seeking out what I believe should be routine and standard care.
— David Saxon, MD
Community Engagement and Advocacy
The Community Advisory Board solicits valuable insights from the community to guide program growth and direction. Direct feedback from the LGBTQ community ensures our program and services are aligned with community needs. Post-visit feedback assists in process optimization, organizational improvement, and visibility where change is needed.
— Keily Fisher, UCH ITP Program Coordinator
|1.||Health considerations for transgender women and remaining unknowns: a narrative review. |
Iwamoto SJ, Defreyne J, Rothman MS, Van Schuylenbergh J, Van de Bruaene L, Motmans J, T'Sjoen G.
Ther Adv Endocrinol Metab. 2019 Aug 30;10:2042018819871166. doi: 10.1177/2042018819871166. eCollection 2019.
PMID: 31516689 Free PMC article. Review.
|2.||Bone Health in the Transgender Population. |
Rothman MS, Iwamoto SJ.
Clin Rev Bone Miner Metab. 2019 Jun;17(2):77-85. doi: 10.1007/s12018-019-09261-3. Epub 2019 Jul 2.
PMID: 31452648 Free PMC article.
|3.||Letter to the Editor: "Progesterone Is Important for Transgender Women's Therapy-Applying Evidence for the Benefits of Progesterone in Ciswomen". |
Iwamoto SJ, T'Sjoen G, Safer JD, Davidge-Pitts CJ, Wierman ME, Glodowski MB, Rothman MS.
J Clin Endocrinol Metab. 2019 Aug 1;104(8):3127-3128. doi: 10.1210/jc.2019-00249.
PMID: 30860591 No abstract available.
|4.||The (Slow) Depathologizing of Gender Incongruence. |
Davies RD, Davies ME.
J Nerv Ment Dis. 2020 Feb;208(2):152-154. doi: 10.1097/NMD.0000000000001119.
|5.||Gender-Affirming Hormone Use in Transgender Individuals: Impact on Behavioral Health and Cognition. |
Nguyen HB, Chavez AM, Lipner E, Hantsoo L, Kornfield SL, Davies RD, Epperson CN.
Curr Psychiatry Rep. 2018 Oct 11;20(12):110. doi: 10.1007/s11920-018-0973-0.
PMID: 30306351 Free PMC article. Review.
|6.||Gender Minority Stress, Depression, and Anxiety in a Transgender High School Student. |
Davies RD, Kessel B.
Am J Psychiatry. 2017 Dec 1;174(12):1151-1152. doi: 10.1176/appi.ajp.2017.17040439.
PMID: 29191036 No abstract available.
|7.||Measuring the Health of an Invisible Population: Lessons from the Colorado Transgender Health Survey. |
Christian R, Mellies AA, Bui AG, Lee R, Kattari L, Gray C.
J Gen Intern Med. 2018 Oct;33(10):1654-1660. doi: 10.1007/s11606-018-4450-6. Epub 2018 May 15.
PMID: 29761263 Free PMC article.
|8.||Technical Refinements of Vulvar Reconstruction in Gender-Affirming Surgery. |
Dy GW, Kaoutzanis C, Zhao L, Bluebond-Langner R.
Plast Reconstr Surg. 2020 May;145(5):984e-987e. doi: 10.1097/PRS.0000000000006796.
|9.||Body Composition and Markers of Cardiometabolic Health in Transgender Youth Compared With Cisgender Youth. |
Nokoff NJ, Scarbro SL, Moreau KL, Zeitler P, Nadeau KJ, Juarez-Colunga E, Kelsey MM.
J Clin Endocrinol Metab. 2020 Mar 1;105(3):e704-14. doi: 10.1210/clinem/dgz029.
PMID: 31544944 Free PMC article.
|10.||Health and Cardiometabolic Disease in Transgender Adults in the United States: Behavioral Risk Factor Surveillance System 2015. |
Nokoff NJ, Scarbro S, Juarez-Colunga E, Moreau KL, Kempe A.
J Endocr Soc. 2018 Mar 5;2(4):349-360. doi: 10.1210/js.2017-00465. eCollection 2018 Apr 1.
PMID: 29577110 Free PMC article.
|11.||Maximizing Resources: Ensuring Standard of Care for a Transgender Child in a Rural Setting. |
Reirden DH, Glover JJ.
Am J Bioeth. 2019 Jul;19(7):66-67. doi: 10.1080/15265161.2019.1618944.
PMID: 31237502 No abstract available.
Primary Care/General Internal Medicine
Rita Lee, MD *
Danielle Loeb, MD, MPH
Robert Davies, MD *
Debbie Carter, MD *
Gynecologic Care & Surgery
Tricia Huguelet, MD *
Veronica Alaniz, MD *
Christodoulos Kaoutzanis, MD
Brooke French, MD *
David Mathes, MD
David Khechoyan, MD
Tae Chong, MD
Shannon Phillips, PA
Ty Higuchi, MD
Paul Maroni, MD
Andrew Winkler, MD
Matthew Clary, MD
Marie Jetté, PhD
Katherine Frasca, MD *
Carla Torres-Zegarra, MD
Pediatric Endocrinology at TRUE Center for Gender Diversity
Daniel Reirden, MD
Natalie Nokoff, MD, MPH
Sarah Bergamy, PsyD *
Lauren Barr, MSW, LCSW
Shelby Daniels, BSN, RN
John Hart, MHA
Keily Fisher (Program Coordinator) *
Professional Research Assistant
Danielle Kline, MS (Senior)
Mary Mancuso, MA